Plaintiff:	CHARLES KEEP and THE ESTATE OF CONNIE KEEP
Defendant:	AUROBINDO PHARMA, LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD., ACTAVIS PHARMA INC., CAMBER PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA, INC., ALBERTSONS COMPANIES LLC, JOHN DOE, AUROBINDO PHARMA USA, INC., HETERO DRUGS LTD., HETERO LABS LIMITED, MYLAN LABORATORIES LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD, MYLAN PHARMACEUTICALS INC., TORRENT PHARMACEUTICALS LTD, ACTAVIS LLC, Acetris, LLC, AVKARE, INC., BRYANT RANCH PREPACK, INC., THE HARVARD DRUG GROUP, LLC D/B/A MAJOR PHARMACEUTICALS, Northwind Phamaceuticals, PREFERRED PHARMACEUTICALS INC., REMEDYREPACK, INC. and HETERO USA, INC.
In Re:	VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Case Number:	1:2022cv02461
Filed:	April 28, 2022
Court:	US District Court for the District of New Jersey
Presiding Judge:	Sharon A King
Referring Judge:	Robert B Kugler
Nature of Suit:	Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Cause of Action:	28 U.S.C. § 1332 Diversity-Product Liability
Jury Demanded By:	Plaintiff

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System

• Search for Party Aliases
• Associated Cases
• Attorneys
• Case File Location
• Case Summary
• Docket Report
• History/Documents
• Parties
• Related Transactions
• Check Status